Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BBOTBBOT
3 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BRIDGEBIO ONCOLOGY THERAPEUT

GOLDMAN SACHS GROUP INC holds 102,085 shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $777,888 as of 2026-Q2. The position was decreased (-39.1% shares). BBOT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$777,888

Current Shares

102,085

Total Value Change

-$407,143

Total Shares Change

+7,434

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
102,085
-39.1%
$777,8880.0%$7.62
0
2026-Q1
Increased
167,573
+77.0%
$1.5M0.0%$9.74
39
2025-Q4
New
94,651
-
$1.2M0.0%$12.37
35

Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used